World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
37799
World Ranking
7082
National Ranking
3722

Robert C. Seeger publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert C. Seeger sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 284 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert C. Seeger D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert C. Seeger sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Robert C. Seeger is affiliated with the Children's Hospital of Los Angeles in the United States. Their research spans multiple fields within medicine and molecular biology with a focus on areas including neurology, oncology, cancer research, molecular biology, and paleontology.

The scientist's work primarily concentrates on neuroblastoma research and treatments, cancer hypoxia and metabolism, lung cancer research, cancer therapeutics and mechanisms, glioma diagnosis and treatment, as well as paleontology and evolutionary biology. These areas reflect a diverse research portfolio with a strong emphasis on cancer and neurological diseases alongside evolutionary studies.

Frequent co-authors collaborating with Robert C. Seeger include Michael J. Zobel, Abigail K. Zamora, Michael A. Sheard, Shahab Asgharzadeh, and Eugene S. Kim. Their partnership appears consistent across multiple projects, highlighting a collaborative approach in their research efforts.

Publications by Robert C. Seeger are found in a variety of scientific journals. The venues include Genome Research, Journal for ImmunoTherapy of Cancer, Frontiers in Ecology and Evolution, Pediatric Blood & Cancer, and Biology of Blood and Marrow Transplantation.

Recent papers illustrate the scope and focus of the scientist's research:

  • Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma, 2020, Genome Research
  • Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice, 2020, Journal for ImmunoTherapy of Cancer
  • Revised Description of the Early Permian Recumbirostran "Microsaur" Nannaroter mckinziei Based on New Fossil Material and Computed Tomographic Data, 2021, Frontiers in Ecology and Evolution
  • Expression of neuroblastoma-related genes in bone marrow at end of high-risk neuroblastoma therapy, 2022, Pediatric Blood & Cancer
  • Significant Targeting of Neuroblastoma By Anti-ROR1 Chimeric Antigen Receptor (CAR) Engineered NK Cells with or without IL-15 Superagonist (N-803) in Vitro and In Vivo Using Human Neuroblastoma Xenografted NSG Mice, 2020, Biology of Blood and Marrow Transplantation

Best Publications

  • Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

    GM Brodeur;RC Seeger;RC Seeger;M Schwab;HE Varmus

  • Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

    Robert C. Seeger;Garrett M. Brodeur;Harland Sather;Andree Dalton

  • Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Alice L. Yu;Andrew L. Gilman;M. Fevzi Ozkaynak;Wendy B. London

  • The genetic landscape of high-risk neuroblastoma

    Trevor J Pugh;Olena Morozova;Edward F Attiyeh;Edward F Attiyeh;Shahab Asgharzadeh;Shahab Asgharzadeh

  • Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

    Katherine K. Matthay;C. Patrick Reynolds;Robert C. Seeger;Hiroyuki Shimada

  • Chromosome 1p and 11q deletions and outcome in neuroblastoma.

    Edward F. Attiyeh;Wendy B. London;Yael P. Mossé;Qun Wang

  • Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

    W.B. London;R.P. Castleberry;K.K. Matthay;A.T. Look

  • Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.

    Steven DuBois;Yan Kalika;John Lukens;Garrett Brodeur

  • Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells

    Leonid S. Metelitsa;Olga V. Naidenko;Anita Kant;Hong-Wei Wu

  • Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines

    Neil Sidell;Adrienne Altman;Mark R. Haussler;Robert C. Seeger

  • Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy

    Kishore B. Challagundla;Petra M. Wise;Paolo Neviani;Haritha Chava

  • ATM is down-regulated by N-Myc–regulated microRNA-421

    Hailiang Hu;Liutao Du;Gindy Nagabayashi;Robert C. Seeger

  • Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

    Mario Capasso;Marcella Devoto;Cuiping Hou;Shahab Asgharzadeh

  • Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages

    Liping Song;Shahab Asgharzadeh;Jill Salo;Kelly Engell

  • Increase of Ceramide and Induction of Mixed Apoptosis/Necrosis by N -(4-Hydroxyphenyl)- retinamide in Neuroblastoma Cell Lines

    Maurer Bj;Metelitsa Ls;Seeger Rc;Cabot Mc

  • Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

    David L. Baker;Mary L. Schmidt;Susan L. Cohn;John M. Maris

  • Morphology, Growth, Chromosomal Pattern, and Fibrinolytic Activity of Two New Human Neuroblastoma Cell Lines

    Robert C. Seeger;Sylvia A. Rayner;Ashu Banerjee;Helen Chung

  • Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma

    John M. Maris;Yael P. Mosse;Jonathan P. Bradfield;Cuiping Hou

  • Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study

    Suzanne S. Shusterman;Wendy B. London;Stephen D. Gillies;Jacquelyn A. Hank

  • Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.

    Chun Guo;Peter S White;Matthew J Weiss;Michael D Hogarty

Frequent Co-Authors

John M. Maris
John M. Maris Children's Hospital of Philadelphia
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Hiroyuki Shimada
Hiroyuki Shimada Stanford University
Richard Sposto
Richard Sposto University of Southern California
Wendy B. London
Wendy B. London Harvard University
Garrett M. Brodeur
Garrett M. Brodeur Children's Hospital of Philadelphia
C. Patrick Reynolds
C. Patrick Reynolds Texas Tech University Health Sciences Center
Daniel O. Stram
Daniel O. Stram University of Southern California
Susan L. Cohn
Susan L. Cohn University of Chicago
Michael D. Hogarty
Michael D. Hogarty Children's Hospital of Philadelphia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine doesn’t always mean following the traditional MD path. There are numerous related degrees that can help you achieve your professional goals—many of which can be earned online with increased flexibility and affordability.

For those already working in healthcare management, you might explore whats the best online mha program for working adults to boost your leadership and administrative skills without putting your career on hold.

Nurses aiming to advance may be interested in rn bsn online programs no clinicals, offering opportunities to earn a BSN without traditional clinical requirements.

If your goal is to reach the highest level of nursing practice, check out online dnp programs. These doctorate-level degrees can often be completed faster online. For those mindful of cost, there are also cheapest dnp programs available, helping you minimize debt while advancing your credentials.

Exploring these alternative online programs can open new avenues in healthcare, providing modern, practical pathways to rewarding medical careers.

Best Scientists Citing Robert C. Seeger

Trending Scientists

Recently Published Articles